Total Payments
$14,649
2024 Payments
$1,543
Companies
42
Transactions
348
Medicare Patients
4,127
Medicare Billing
$514,873
Payment Breakdown by Category
Food & Beverage$8,252 (56.3%)
Other$4,526 (30.9%)
Travel$1,757 (12.0%)
Education$112.79 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,252 | 329 | 56.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3,900 | 4 | 26.6% |
| Travel and Lodging | $1,757 | 12 | 12.0% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $626.40 | 1 | 4.3% |
| Education | $112.79 | 2 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Nestle HealthCare Nutrition Inc. | $2,829 | 15 | $0 (2022) |
| ABBVIE INC. | $2,212 | 120 | $0 (2024) |
| QOL Medical, LLC | $1,616 | 14 | $0 (2023) |
| Boston Scientific Corporation | $962.01 | 9 | $0 (2024) |
| Endogastric Solutions, Inc | $709.02 | 5 | $0 (2020) |
| Cook Incorporated | $626.40 | 1 | $0 (2017) |
| Olympus Corporation of the Americas | $607.62 | 9 | $0 (2019) |
| Apollo Endosurgery US Inc | $518.74 | 4 | $0 (2017) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $460.36 | 28 | $0 (2024) |
| Gilead Sciences, Inc. | $456.28 | 18 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,543 | 63 | ABBVIE INC. ($716.92) |
| 2023 | $1,038 | 49 | AbbVie Inc. ($433.32) |
| 2022 | $1,083 | 48 | ABBVIE INC. ($292.33) |
| 2021 | $3,629 | 51 | Nestle HealthCare Nutrition Inc. ($2,782) |
| 2020 | $2,561 | 33 | QOL Medical, LLC ($1,460) |
| 2019 | $1,821 | 44 | Olympus Corporation of the Americas ($607.62) |
| 2018 | $894.99 | 28 | AbbVie, Inc. ($256.86) |
| 2017 | $2,080 | 32 | Cook Incorporated ($626.40) |
All Payment Transactions
348 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: Gastroenterology | ||||||
| 12/13/2024 | Boston Scientific Corporation | OverStitch NXT Endoscopic Suturing System (Device) | Food and Beverage | In-kind items and services | $191.29 | General |
| Category: OverStitch NXT Endoscopic Suture System_ENDO | ||||||
| 12/13/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $9.44 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | Boston Scientific Corporation | OverStitch NXT Endoscopic Suturing System (Device) | Travel and Lodging | In-kind items and services | $157.60 | General |
| Category: OverStitch NXT Endoscopic Suture System_ENDO | ||||||
| 11/27/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $21.67 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/22/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $33.24 | General |
| 11/12/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/09/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $24.09 | General |
| Category: IMMUNOLOGY | ||||||
| 11/08/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $8.64 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $27.51 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/30/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $7.76 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/22/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $31.33 | General |
| Category: IMMUNOLOGY | ||||||
| 10/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $27.62 | General |
| Category: IMMUNOLOGY | ||||||
| 10/17/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $9.36 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/02/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $11.49 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/01/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $27.45 | General |
| Category: GI | ||||||
| 09/21/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $9.09 | General |
| Category: IMMUNOLOGY | ||||||
| 09/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/16/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $28.53 | General |
| 09/13/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $22.27 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/10/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $17.83 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/04/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $12.66 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/30/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/23/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $30.45 | General |
| Category: IMMUNOLOGY | ||||||
| 08/21/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $7.87 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 959 | 1,498 | $646,453 | $123,255 |
| 2022 | 22 | 1,169 | 1,620 | $792,728 | $151,677 |
| 2021 | 23 | 1,137 | 1,387 | $734,265 | $136,938 |
| 2020 | 19 | 862 | 955 | $573,364 | $103,003 |
Total Patients
4,127
Total Services
5,460
Medicare Billing
$514,873
Procedure Codes
82
All Medicare Procedures & Services
82 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 105 | 175 | $46,900 | $16,277 | 34.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 110 | 112 | $52,034 | $14,678 | 28.2% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 64 | 64 | $88,192 | $12,358 | 14.0% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 26 | 301 | $36,722 | $10,794 | 29.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 122 | 139 | $26,132 | $9,161 | 35.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 72 | 72 | $30,744 | $8,963 | 29.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 85 | 101 | $28,179 | $8,930 | 31.7% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 27 | 178 | $19,580 | $8,200 | 41.9% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 88 | 91 | $97,461 | $6,431 | 6.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 42 | 42 | $51,324 | $5,105 | 9.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 68 | 68 | $19,108 | $5,050 | 26.4% |
| 43242 | Ultrasound guided needle aspiration or biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 21 | 21 | $15,456 | $4,022 | 26.0% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 45 | 45 | $36,754 | $3,957 | 10.8% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 22 | 22 | $20,942 | $2,767 | 13.2% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 15 | 15 | $14,940 | $2,726 | 18.2% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 19 | 20 | $55,854 | $2,116 | 3.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 11 | 11 | $4,136 | $1,340 | 32.4% |
| 74328 | Review by radiologist of image from tube placement into bile duct using an endoscope | Facility | 2023 | 17 | 21 | $1,995 | $380.52 | 19.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 144 | 147 | $76,725 | $22,558 | 29.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 115 | 215 | $57,897 | $17,445 | 30.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 121 | 152 | $42,408 | $14,418 | 34.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 106 | 106 | $45,262 | $12,660 | 28.0% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 60 | 60 | $81,998 | $11,532 | 14.1% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 27 | 222 | $25,336 | $8,357 | 33.0% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 72 | 72 | $87,984 | $7,981 | 9.1% |
About Dr. Tarek Ammar, MD
Dr. Tarek Ammar, MD is a Gastroenterology healthcare provider based in Las Vegas, Nevada. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/05/2007. The National Provider Identifier (NPI) number assigned to this provider is 1649478314.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Tarek Ammar, MD has received a total of $14,649 in payments from pharmaceutical and medical device companies, with $1,543 received in 2024. These payments were reported across 348 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($8,252).
As a Medicare-enrolled provider, Ammar has provided services to 4,127 Medicare beneficiaries, totaling 5,460 services with total Medicare billing of $514,873. Data is available for 4 years (2020–2023), covering 82 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Other Specialties Gastroenterology
- Location Las Vegas, NV
- Active Since 07/05/2007
- Last Updated 02/18/2021
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1649478314
Products in Payments
- ZENPEP (Drug) $2,861
- Sucraid (Drug) $1,563
- ESOPHYX (Device) $709.02
- Olympus EMR & ESD Devices (Device) $607.62
- RINVOQ (Biological) $529.23
- LINZESS (Drug) $475.22
- Orbera (Device) $368.96
- Humira (Biological) $361.83
- OverStitch NXT Endoscopic Suturing System (Device) $348.89
- CREON (Drug) $315.19
- STELARA (Biological) $287.04
- SKYRIZI (Biological) $279.71
- HUMIRA (Biological) $277.05
- XIFAXAN (Drug) $262.32
- ERBE (Device) $201.93
- VIO300D, APC2 (Device) $187.58
- Manometry (Device) $184.02
- SpaceOAR VUE System - 10mL (Device) $174.64
- LINX Reflux Management System (Device) $162.05
- OVERSTITCH (Device) $149.78
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Las Vegas
Dr. Christian Stone, Md, Mph, MD, MPH
Gastroenterology — Payments: $1.3M
Gastroenterology $1.3M
Dr. Vijay Jayaraman, M.d, M.D
Gastroenterology — Payments: $40,497
Gastroenterology $40,497
Dr. Noel Fajardo, M.d, M.D
Gastroenterology — Payments: $40,481
Gastroenterology $40,481
Gary Chen, M.d, M.D
Gastroenterology — Payments: $29,963
Gastroenterology $29,963
Uday Saraiya, Md, MD
Gastroenterology — Payments: $26,455
Gastroenterology $26,455
David Shih, Md, MD
Gastroenterology — Payments: $25,941
Gastroenterology $25,941